Catalyst Pharmaceuticals (CPRX) is a publicly traded Healthcare sector company. As of July 10, 2026, CPRX trades at $31.48 with a market cap of $3.85B and a P/E ratio of 17.39. CPRX moved +0.03% today. Year to date, CPRX is +34.83%; over the trailing twelve months it is +45.53%. Its 52-week range spans $19.05 to $32.56. Analyst consensus is neutral with an average price target of $32.40. Rallies surfaces CPRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for CPRX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $31.48 |
| Market Cap | $3.85B |
| P/E Ratio | 17.39 |
| EPS | $1.81 |
| Dividend Yield | 0.00% |
| 52-Week High | $32.56 |
| 52-Week Low | $19.05 |
| Volume | 901.09K |
| Avg Volume | 0 |
| Revenue (TTM) | $596.96M |
| Net Income | $221.32M |
| Gross Margin | 85.96% |
6 analysts cover CPRX: 0 strong buy, 1 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $32.40.